BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services

Lonza to Acquire Five US CDMO Sites from Merck KGaA to Double Manufacturing Footprint

Lonza acquires five CDMO manufacturing sites and approximately 1,100 highly skilled employees, more than doubling its US footprint to nine CDMO sites wit...

November 04, 2026 | News

Zhimeng Biopharma Completes Enrolment of 255 Patients in Pivotal ALS Phase II/III Trial in China

Shanghai Zhimeng Biopharma, Inc. ( "Zhimeng Biopharma") announced that its independently developed next-generation potassium channel opener, CB03-154,...

November 03, 2026 | News

ESTEVE CDMO Invests Over $80 Million to Expand Pharmaceutical Manufacturing Capabilities in China

After more than two decades in China, ESTEVE CDMO marks a new chapter in its commitment to the country and the region. With more than $...

October 23, 2026 | News

360biolabs Expands Australian Footprint with New Bioanalytical Laboratory in Sydney

The new 360biolabs facility in North Ryde is strategically located within one of Sydney’s vibrant science and medtech hubs, Macquarie Park In...

October 14, 2026 | News

LOTTE Biologics and Alvotech Forge Long-Term Partnership to Expand Global Biosimilar Manufacturing Capacity

Collaboration covers multiple biosimilar products to be manufactured at LOTTE Biologics' Syracuse facility in New York Strategic long-term partnershi...

October 13, 2026 | News

Lonza and Asimov Partner to Advance Lentiviral Vector Manufacturing for In Vivo Therapies

Collaboration connects Asimov’s genetic design and cell line technologies with Lonza’s process development, scale-up and GMP manufacturin...

October 05, 2026 | News

Vetter Accelerates Injectable Manufacturing Expansion to Meet Rising Global Demand

Vetter, a leading Contract Development and Manufacturing Organization (CDMO), continues to expand its commercial fill-and-finish network to further s...

September 29, 2026 | News

WuXi XDC Achieves GMP Release for Singapore Bioconjugate Manufacturing Site

WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on t...

September 23, 2026 | News

Australia’s VVMF Secures TGA GMP Licence for Viral Vector Manufacturing

Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first viral vector Contract Development and Manufacturing Organisation (CDMO) advises...

September 18, 2026 | News

Altruist Biologics Supports LongBio Pharma’s LP-003 to NMPA BLA Acceptance in China

Enabled by Altruist's integrated CMC development platform, GMP manufacturing and regulatory service capabilities, LP-003 has successfully advanced from c...

September 17, 2026 | News

Single Cell Discoveries Acquires TATAA Biocenter to Build Integrated Discovery-to-Validation CRO

Single Cell Discoveries (SCD), a specialist contract research organization (CRO) focused on discovery transcriptomics, has completed the acquisition of TAT...

September 16, 2026 | News

Novo Holdings Makes Strategic Investment in China’s Wound Care CDMO ForYou Medical

Novo Holdings, a leading global healthcare and life sciences investor, announced a strategic minority investment in Huizhou ForYou Medical Devices Co., Ltd...

September 14, 2026 | News

Transcenta Licenses HiCB Bioprocessing Technology to WuXi Biologics in Strategic Collaboration

Transcenta Therapeutics (HKEX: 06628), a global clinical-stage biopharmaceutical company with fully integrated capabilities in discovery, R&D and proce...

September 11, 2026 | News

CordenPharma Invests €80M to Expand Sterile Injectable Manufacturing Capacity in Italy

CordenPharma accelerates sterile injectable CDMO manufacturing expansion with €80 million multi-year investment in new facility and additional as...

September 11, 2026 | News

Stay Connected